CLINICAL_TRIALS
trial_result
· 2011-05-17
Clinical Trial Update: Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating the efficacy and safety of SU-014813 in patients with metastatic breast cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED